» Articles » PMID: 23620186

OT-1 Mice Display Minimal Upper Genital Tract Pathology Following Primary Intravaginal Chlamydia Muridarum Infection

Overview
Journal Pathog Dis
Date 2013 Apr 27
PMID 23620186
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Chlamydia trachomatis is the most common bacterial sexually transmitted disease worldwide and leads to serious pathological sequelae in the upper genital tract (UGT) including pelvic inflammatory disease, ectopic pregnancy, and infertility. Several components of the host immune responses have been shown to contribute to the UGT pathology following genital chlamydial infection. We have shown recently that CD8(+) T cells induce the chlamydial UGT pathology via the production of TNF-α. However, those studies did not determine whether the pathology is mediated by bystander or antigen-specific CD8(+) T cells. In this study, we compared chlamydial clearance and UGT pathology in OT-1 transgenic mice and the corresponding C57BL/6J wild-type mice following primary intravaginal Chlamydia muridarum infection. All CD8(+) T cells in the OT-1 mice respond only to the Ova 257-264 peptide and are incapable of responding to other antigenic epitopes including those of Chlamydia. OT-1 mice displayed vaginal chlamydial clearance comparable to the wild-type animals. However, both oviduct and uterine horn pathology were minimal in the OT-1 mice compared with the high degree of pathology observed in the wild-type animals. These results strongly suggest that Chlamydia-specific, not bystander, CD8(+) T cells mediate the UGT pathological sequelae following genital chlamydial infection.

Citing Articles

Viral Vector-Based Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice.

Andreacchio G, Longo Y, Moreno Mascaraque S, Anandasothy K, Tofan S, Ozun E Vaccines (Basel). 2024; 12(8).

PMID: 39204067 PMC: 11360449. DOI: 10.3390/vaccines12080944.


Protective anti-chlamydial vaccine regimen-induced CD4+ T cell response mediates early inhibition of pathogenic CD8+ T cell response following genital challenge.

Murthy A, Wright-McAfee E, Warda K, Moy L, Bui N, Musunuri T Pathog Dis. 2024; 82.

PMID: 38684476 PMC: 11149721. DOI: 10.1093/femspd/ftae008.


IgG exacerbates genital chlamydial pathology in females by enhancing pathogenic CD8 T cell responses.

Armitage C, OMeara C, Bryan E, Kollipara A, Trim L, Hickey D Scand J Immunol. 2024; 99(1):e13331.

PMID: 38441219 PMC: 10909563. DOI: 10.1111/sji.13331.


transmitting from the genital to gastrointestinal tract and inducing tubal disease: Double attack pattern. .

Xu Y, Wang J Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022; 47(9):1275-1280.

PMID: 36411712 PMC: 10930326. DOI: 10.11817/j.issn.1672-7347.2022.220023.


Characterization of Pathogenic CD8 T cells in Chlamydia-Infected OT1 Mice.

Zhou Z, Tian Q, Wang L, Sun X, Zhang N, Xue M Infect Immun. 2021; 90(1):e0045321.

PMID: 34724387 PMC: 8788780. DOI: 10.1128/IAI.00453-21.


References
1.
Darville T, ONeill J, Andrews Jr C, Nagarajan U, Stahl L, Ojcius D . Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol. 2003; 171(11):6187-97. DOI: 10.4049/jimmunol.171.11.6187. View

2.
Prantner D, Darville T, Sikes J, Andrews Jr C, Brade H, Rank R . Critical role for interleukin-1beta (IL-1beta) during Chlamydia muridarum genital infection and bacterial replication-independent secretion of IL-1beta in mouse macrophages. Infect Immun. 2009; 77(12):5334-46. PMC: 2786476. DOI: 10.1128/IAI.00883-09. View

3.
Murthy A, Li W, Chaganty B, Kamalakaran S, Guentzel M, Seshu J . Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun. 2011; 79(7):2928-35. PMC: 3191981. DOI: 10.1128/IAI.05022-11. View

4.
Morrison R, Caldwell H . Immunity to murine chlamydial genital infection. Infect Immun. 2002; 70(6):2741-51. PMC: 128027. DOI: 10.1128/IAI.70.6.2741-2751.2002. View

5.
Brunham R, Rey-Ladino J . Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol. 2005; 5(2):149-61. DOI: 10.1038/nri1551. View